Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

The impact of surgical excision in chest wall rhabdomyosarcoma: a report from the children's oncology group

  • Andrea Hayes-Jordan
  • , Julie A. Stoner
  • , James R. Anderson
  • , David Rodeberg
  • , Gene Weiner
  • , William H. Meyer
  • , Doug S. Hawkins
  • , Carola A.S. Arndt
  • , Charles Paidas
  • University of Texas MD Anderson Cancer Center
  • University of Nebraska Medical Center
  • University of Pittsburgh
  • University of Oklahoma
  • Seattle Children's
  • Mayo Clinic Rochester, MN
  • Johns Hopkins All Children's

Producción científicarevisión exhaustiva

33 Citas (Scopus)

Resumen

Aims: Rhabdomyosarcoma (RMS) is the most common soft tissue tumor of childhood. Patient age, size, histologic finding, and site of the tumor are primary determinants of prognosis in RMS. Chest wall RMS is a site in which the limitations of surgical excision are realized. We aim to determine the impact of surgical excision in chest wall RMS. Methods: A retrospective chart review was conducted of all 130 pediatric patients enrolled in the Intergroup Rhabdomyosarcoma Study (IRS) with chest wall rhabdomyosarcoma from the first (I) through fourth (IV) IRS with follow-up to June 2005. Median follow-up was 12.1 years (4.6-27.2 years). Results: There was a significant improvement in failure-free survival (FFS) and overall survival (OS) between the first IRS study, I, and IRS-IV. The estimated FFS and OS at 5 years in IRS I was 30% and 40%, respectively, compared to 68% and 78%, respectively, in IRS-IV (P = .03 and P = .05, respectively). There was no association between histologic finding or size and FFS or OS. However, all patients who presented without metastasis had an FFS and OS of 49% and 61%, respectively, compared with metastatic patients, 7% and 7%, respectively (P < .001). Five-year FFS of group I, II, and III patients was 52%, 52%, and 45%, respectively, and OS was 65%, 60%, and 59%, respectively. There was no significant difference in 5-year FFS or OS in patients who had a complete resection (group I), complete resection with positive microscopic margins (group II), or biopsy or partial resection only (group III). In groups I to III patients, the local and regional failure rate at 5 years is 25% and 6%, respectively. Conclusions: The most significant impact on outcome in chest wall RMS patients is metastatic disease at diagnosis. The locoregional failure rate is high but does not appear to impact survival. Alternative treatment strategies are needed for chest wall RMS, but aggressive surgical excision may not be necessary.

Idioma originalEnglish
Páginas (desde-hasta)831-836
Número de páginas6
PublicaciónJournal of Pediatric Surgery
Volumen43
N.º5
DOI
EstadoPublished - may 2008
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'The impact of surgical excision in chest wall rhabdomyosarcoma: a report from the children's oncology group'. En conjunto forman una huella única.

Citar esto